These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20062922)

  • 1. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
    Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M
    Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
    Nogami K; Shima M; Nishiya K; Sakurai Y; Tanaka I; Giddings JC; Saenko EL; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.
    Yada K; Nogami K; Ogiwara K; Shibata M; Shima M
    Thromb Haemost; 2011 Jun; 105(6):989-98. PubMed ID: 21437361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies.
    Matsumoto T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2012 Feb; 107(2):288-301. PubMed ID: 22234708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a thrombin-interactive site within the FVIII A2 domain that is responsible for the cleavage at Arg372.
    Nogami K; Saenko EL; Takeyama M; Giddings JC; Yoshioka A; Shima M
    Br J Haematol; 2008 Feb; 140(4):433-43. PubMed ID: 18081893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
    Yada K; Nogami K; Shima M
    Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the B domain in proteolytic inactivation of activated coagulation factor VIII by activated protein C and activated factor X.
    Khrenov AV; Ananyeva NM; Saenko EL
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):379-88. PubMed ID: 16788314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-heavy-chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor.
    Raut S; Villard S; Grailly S; Gilles JG; Granier C; Saint-Remy JM; Barrowcliffe TW
    Thromb Haemost; 2003 Sep; 90(3):385-97. PubMed ID: 12958606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin G, a leukocyte protease, activates coagulation factor VIII.
    Gale AJ; Rozenshteyn D
    Thromb Haemost; 2008 Jan; 99(1):44-51. PubMed ID: 18217133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
    Johnson DJ; Pemberton S; Acquila M; Mori PG; Tuddenham EG; O'Brien DP
    Thromb Haemost; 1994 Apr; 71(4):428-33. PubMed ID: 8052958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
    Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of factor VIII inactivation by human antibodies. III. Proteolytic cleavage of factor VIII:C and C antigen by thrombin.
    Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
    Ann Clin Lab Sci; 1985; 15(6):482-7. PubMed ID: 3933404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
    Switzer ME; McKee PA
    J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin potentiation of factor VIII procoagulant activity: assessment by the two-stage assay.
    Kopitsky RG; Switzer ME; McKee PA
    Thromb Haemost; 1982 Apr; 47(2):145-9. PubMed ID: 6213066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
    Scandella D
    Vox Sang; 1996; 70 Suppl 1():9-14. PubMed ID: 8869462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.